Why Did Aurora Cannabis (TSX:ACB) Stock Lose $12 Billion in Value?

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) was once worth more than $10 billion. What went wrong?

| More on:

Aurora Cannabis (TSX:ACB)(NYSE:ACB) was once the hottest cannabis stock in the world. In 2016, shares tripled. In 2017, they quadrupled. In 2018, the stock hit a high of $14, when just a few years prior, it was valued at $0.50.

Last year, everything changed. The bear market of 2019 may ultimately go down as one of the most painful periods in cannabis history. Billion-dollar companies were forced to the brink of collapse. Even the best-financed competitors saw share price declines exceed 80%.

Aurora was unable to avoid destruction. After achieving a valuation of $15 billion in 2018, the company’s market cap has been reduced to just $3 billion.

Such rapid downward moves are rare. What happened? More importantly, can you take advantage by buying battered shares? If the company ever regains its former glory, there would be at least 1,000% upside.

Here’s what happened

During Aurora’s atmospheric rise, it’s difficult to tell just how special the company was. In 2017, for example, shares surged 400%, but stocks like Cronos Group, Canopy Growth, Hexo, and more posted similar gains. Any company even loosely related to cannabis saw its valuation skyrocket.

It’s difficult to glean any lessons from this period. It was a classic hype cycle — a rising-tide-lifts-all-boats situation.

Actually, the best time to learn something was during the bear market of 2019. Similar to the rise of 2017, last year punished every company in the industry. It was an indiscriminate sell-off, yet the positioning of different companies has become clear. We’ve also gotten a glimpse into what cannabis producers need to do to achieve long-term success.

For example, Tilray stock sank last summer after revealing its average realized price per gram dropped 28% to $4.61. Other producers later reported similar struggles.

I immediately thought of a report from The Guardian the year prior, which stated that Oregon’s “glut of marijuana — over one million pounds of unsold pot — is in many ways the result of an industry still finding its feet.” Canada is experiencing a similar evolution, with the deleterious effects of commoditization only beginning to be felt.

State of affairs

Commoditization is the number one risk for the entire cannabis industry. Despite the feeling that marijuana is different, it’s, in many ways, no more difficult to grow than any other crop. As markets open and industry supply scales, it will be a race to the bottom for pricing. Take a look at any major dairy producer — some of which have already gone bankrupt this year — and you’ll understand how difficult it is to peddle in a pure commodity.

The future, then, will be predicated on brands. Oreos, Coke, and Heinz are all made from commoditized ingredients, yet command premium pricing due to consumer loyalty. The cannabis company that can copy this playbook for pot will win.

Let’s look at the competition. Cronos Group is working with tobacco giant Altria Group, which owns world-renowned brands like Marlboro. Canopy Growth has partnered with Constellation Brands, which distributes popular brands like Corona and Modelo. Hexo, meanwhile, has already co-created a cannabis beverage with Molson Coors Canada. Tilray struck a deal with an Anheuser Busch InBev subsidiary.

Aurora has secured several partnerships, but none as large as its competitors. That means it will need to develop its brands from scratch. Its peers, meanwhile, can leverage existing brands that hundreds of millions of consumers already know and love.

If the future of cannabis is brand power, Aurora is at a clear disadvantage. Until it proves otherwise, shares will trade at a discount.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends Anheuser-Busch InBev NV, Constellation Brands, HEXO., and HEXO. Fool contributor Ryan Vanzo has no position in any stocks mentioned. 

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »